Topotecan injection
Products billed under this code include Topotecan.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Topotecan.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Topotecan | Pfizer Inc | 00409-0302-01 | 40 | $82.68 |
| Topotecan | Accord Healthcare Inc | 16729-0151-31 | 40 | $82.68 |
| Topotecan | Accord Healthcare Inc | 16729-0243-31 | 40 | $82.68 |
| Topotecan | Actavis Pharma, Inc. | 45963-0615-56 | 40 | $82.68 |
| Topotecan | FreseniUS Kabi USA, LLC | 63323-0762-10 | 40 | $82.68 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.067 | −$0.692 | 0.1 MG | Topotecan injection | v1, posted September 17, 2026 |
| 3Q26 | $2.759 | +$0.648 | 0.1 MG | Topotecan injection | v1, posted September 15, 2026 |
| 2Q26 | $2.111 | +$0.863 | 0.1 MG | Topotecan injection | v1, posted September 15, 2026 |
| 1Q26 | $1.248 | −$1.293 | 0.1 MG | Topotecan injection | v1, posted September 15, 2026 |
| 4Q25 | $2.541 | +$1.199 | 0.1 MG | Topotecan injection | v1, posted September 8, 2026 |
| 3Q25 | $1.342 | +$0.069 | 0.1 MG | Topotecan injection | v1, posted March 10, 2026 |
| 2Q25 | $1.273 | −$0.511 | 0.1 MG | Topotecan injection | v1, posted March 10, 2026 |
| 1Q25 | $1.784 | +$0.165 | 0.1 MG | Topotecan injection | v1, posted December 19, 2025 |
| 4Q24 | $1.619 | +$0.681 | 0.1 MG | Topotecan injection | v1, posted June 11, 2025 |
| 3Q24 | $0.938 | −$0.231 | 0.1 MG | Topotecan injection | v1, posted June 11, 2025 |
| 2Q24 | $1.169 | +$0.388 | 0.1 MG | Topotecan injection | v1, posted March 11, 2025 |
| 1Q24 | $0.781 | −$0.304 | 0.1 MG | Topotecan injection | v1, posted December 19, 2024 |
| 4Q23 | $1.085 | +$0.586 | 0.1 MG | Topotecan injection | v1, posted October 10, 2024 |
| 3Q23 | $0.499 | −$0.684 | 0.1 MG | Topotecan injection | v1, posted June 5, 2024 |
| 2Q23 | $1.183 | +$0.359 | 0.1 MG | Topotecan injection | v1, posted February 23, 2024 |
| 1Q23 | $0.824 | −$0.285 | 0.1 MG | Topotecan injection | v1, posted December 6, 2023 |
| 4Q22 | $1.109 | +$0.278 | 0.1 MG | Topotecan injection | v1, posted June 22, 2023 |
| 3Q22 | $0.831 | −$0.285 | 0.1 MG | Topotecan injection | v1, posted June 9, 2023 |
| 2Q22 | $1.116 | +$0.217 | 0.1 MG | Topotecan injection | v1, posted December 14, 2022 |
| 1Q22 | $0.899 | +$0.133 | 0.1 MG | Topotecan injection | v1, posted June 8, 2022 |
| 4Q21 | $0.766 | −$0.322 | 0.1 MG | Topotecan injection | v1, posted June 2, 2022 |
| 3Q21 | $1.088 | −$0.086 | 0.1 MG | Topotecan injection | v1, posted June 2, 2022 |
| 2Q21 | $1.174 | +$0.058 | 0.1 MG | Topotecan injection | v1, posted March 1, 2022 |
| 1Q21 | $1.116 | – | 0.1 MG | Topotecan injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.